regulatory pathway and applications in drug development for rare diseases
Published 1 year ago • 110 plays • Length 1:24:07Download video MP4
Download video MP3
Similar videos
-
29:30
accelerating drug development for rare diseases through data sharing and analysis
-
48:02
rdca-dap - value of integrated data and analytics in rare disease drug development
-
58:25
regulatory pathways, government policy, and related considerations for rare diseases and beyond
-
53:31
ai-powered real-world simulations for faster and value-based rare disease drug development
-
59:23
what does patient focused drug development look like for rare diseases sd 480p
-
1:50
rare disease drug development education series trailer
-
4:33
the drug development process
-
2:46
stories with pacbio: a path for hope
-
45:31
derisking rare disease drug development and measuring impact and outcomes with andrew lo
-
29:30
accelerating drug development for rare diseases through data sharing and analysis
-
2:27
jane larkindale - why are c-path drug development tools important in rare disease drug development?
-
1:36:06
webinar: rdca-dap and eatris present rare disease drug development
-
57:08
industry perspective on drug development in rare diseases
-
4:58:26
opportunities to improve dose finding and optimization for rare disease drug development recording
-
1:59
jane larkindale - what is c-path doing that is unique in drug development for rare disease?
-
11:08
rare disease endpoint advancement rdea pilot program
-
4:00:46
c-path rare and orphan disease conference day two am sessions
-
53:31
a continuity of drug development for diseases across the lifespan
-
55:37
orphan drug & rare disease development: understanding the european and us regulatory landscape